An understanding of discordant SARS-CoV-2 test results: an examination of the data from a central Auckland laboratory

被引:0
|
作者
Fox-Lewis, Shivani [1 ]
Muttaiyah, Sharmini [2 ]
Rahnama, Fahimeh [3 ]
McAuliffe, Gary [2 ]
Roberts, Sally [2 ,4 ]
机构
[1] Auckland City Hosp, Virol Dept, LabPlus, POB 110031, Auckland 1148, New Zealand
[2] Auckland City Hosp, Microbiol Dept, LabPlus, Auckland, New Zealand
[3] Auckland City Hosp, Virol Dept, LabPlus, Mol Diagnost, Auckland, New Zealand
[4] Auckland City Hosp, Microbiol Dept, LabPlus, Microbiol, Auckland, New Zealand
关键词
SENSITIVITY; CT;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AIM: The diagnostic sensitivity of the SARS-CoV-2 real time reverse transcription polymerase chain reaction (RT-PCR) test has not been determined. This has led to a degree of uncertainty in the interpretation of results, particularly in patients tested repeatedly. The aim of this study was to explore the characteristics of patients who initially tested negative, and subsequently tested positive for SARS-CoV-2. METHODS: This retrospective observational study utilised data from the LabPlus Virology laboratory, Auckland City Hospital, to identify cases (hospital and community) with initial negative and subsequent positive SARS-CoV-2 RT-PCR results. Their clinical and laboratory characteristics were summarised. RESULTS: From 1 February to 13 April a total of 20,089 samples were received for SARS-CoV-2 testing. Of 2,011 samples from patients with multiple tests, 25 samples were positive. Nine samples were from patients who initially tested negative then tested positive. Reasons for the initial negative test results, which were all from upper respiratory tract samples, included pre-symptomatic presentation or late presentation. All patients had significant risk factors and ongoing or evolving symptoms, which warranted repeat testing. CONCLUSION: Few patients had discordant test results for SARS-CoV-2 RT-PCR. For patients who have a significant risk factor and a negative test result, repeat testing should be performed.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 50 条
  • [1] Model for Interpreting Discordant SARS-CoV-2 Diagnostic Test Results
    Egbelowo, Oluwaseun F.
    Fox, Spencer J.
    Gibson, Graham C.
    Meyers, Lauren Ancel
    [J]. EMERGING INFECTIOUS DISEASES, 2024, 30 (02) : 388 - 391
  • [2] Understanding Laboratory Testing for SARS-CoV-2
    Cheema, Ritu
    Blumberg, Dean A.
    [J]. CHILDREN-BASEL, 2021, 8 (05):
  • [3] Interpreting SARS-CoV-2 Test Results
    Coffey, K. C.
    Diekema, Daniel J.
    Morgan, Daniel J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (15): : 1528 - 1529
  • [4] SARS-CoV-2 not made in a laboratory
    Mellis, Craig
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2021, 57 (01) : 168 - 168
  • [5] Laboratory Evaluation of a SARS-CoV-2 RT-LAMP Test
    Menting, Sandra
    Erhart, Annette
    Schallig, Henk D. F. H.
    [J]. TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2023, 8 (06)
  • [6] Understanding variants of SARS-CoV-2
    Burki, Talha
    [J]. LANCET, 2021, 397 (10273): : 462 - 462
  • [7] Understanding protection from SARS-CoV-2 using metabolomics
    Barberis, Elettra
    Amede, Elia
    Tavecchia, Matteo
    Marengo, Emilio
    Cittone, Micol G.
    Rizzi, Eleonora
    Pedrinelli, Anita R.
    Tonello, Stelvio
    Minisini, Rosalba
    Pirisi, Mario
    Manfredi, Marcello
    Sainaghi, Pier Paolo
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] Understanding protection from SARS-CoV-2 using metabolomics
    Elettra Barberis
    Elia Amede
    Matteo Tavecchia
    Emilio Marengo
    Micol G. Cittone
    Eleonora Rizzi
    Anita R. Pedrinelli
    Stelvio Tonello
    Rosalba Minisini
    Mario Pirisi
    Marcello Manfredi
    Pier Paolo Sainaghi
    [J]. Scientific Reports, 11
  • [9] Understanding protection from SARS-CoV-2 by studying reinfection
    Overbaugh, Julie
    [J]. NATURE MEDICINE, 2020, 26 (11) : 1680 - 1681
  • [10] Understanding protection from SARS-CoV-2 by studying reinfection
    Julie Overbaugh
    [J]. Nature Medicine, 2020, 26 : 1680 - 1681